Home / COR-NTD / NTD ConnectOR / Doxycycline for Clinical Management of Filarial Lymphedema (Mali)

Doxycycline for Clinical Management of Filarial Lymphedema (Mali)

Determine whether doxycycline treatment daily for 6 weeks improves clinical outcomes (swelling, acute attacks) in lymphedema patients.

Sites

Implementation partner(s): Mali MOH
WHO Region: AFRO

Publications

The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis.

Horton, J., Klarmann-Schulz, U., Stephens, M. et al.
Parasites & Vectors
2020, Issue no. 13, pages 155

Notes

This trial is associated with Doxycycline for Clinical Management of Filarial Lymphedema (Sri Lanka) and Doxycycline for Clinical Management of Filarial Lymphedema (India).

The National Clinical Trials registry number for this project is NCT02927496.

Email primary contact

Please log in or register